CSS
AUPH icon

Cubist Systematic Strategies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Cubist Systematic Strategies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$560K Buy
+50,685
New +$554K ﹤0.01% 2229
2025
Q1 		– Sell
-168,252
Closed -$1.51M – 2848
2024
Q4 		$1.51M Buy
168,252
+147,843
+724% +$1.21M 0.01% 1548
2024
Q3 		$150K Buy
+20,409
New +$127K ﹤0.01% 2636
2024
Q1 		– Sell
-88,622
Closed -$797K – 3701
2023
Q4 		$797K Buy
+88,622
New +$730K 0.01% 2218
2023
Q3 		– Sell
-25,038
Closed -$242K – 3324
2023
Q2 		$242K Sell
25,038
-245,986
-91% -$2.55M ﹤0.01% 2726
2023
Q1 		$2.97M Buy
271,024
+143,375
+112% +$1.26M 0.02% 1351
2022
Q4 		$551K Sell
127,649
-58,330
-31% -$338K ﹤0.01% 2954
2022
Q3 		$1.4M Buy
+185,979
New +$1.61M 0.01% 2335
2022
Q2 		– Sell
-274,374
Closed -$3.4M – 4356
2022
Q1 		$3.4M Buy
+274,374
New +$4.24M 0.03% 1044
2021
Q2 		– Sell
-3,889
Closed -$50K – 2915
2021
Q1 		$50K Buy
3,889
+2,033
+110% +$29.5K ﹤0.01% 2734
2020
Q4 		$26K Buy
1,856
+1,411
+317% +$20.5K ﹤0.01% 2494
2020
Q3 		$7K Sell
445
-25,306
-98% -$367K ﹤0.01% 2441
2020
Q2 		$418K Sell
25,751
-8,636
-25% -$138K 0.01% 1684
2020
Q1 		$499K Buy
34,387
+31,080
+940% +$548K 0.01% 1261
2019
Q4 		$67K Sell
3,307
-2,465
-43% -$22.7K ﹤0.01% 2255
2019
Q3 		$31K Buy
5,772
+5,372
+1,343% +$32.5K ﹤0.01% 2092
2019
Q2 		$3K Sell
400
-27,700
-99% -$177K ﹤0.01% 2419
2019
Q1 		$183K Buy
28,100
+8,000
+40% +$53.1K 0.01% 1830
2018
Q4 		$137K Buy
+20,100
New +$116K 0.01% 1673
2018
Q1 		– Sell
-3,472
Closed -$16K – 1829
2017
Q4 		$16K Buy
+3,472
New +$19.3K ﹤0.01% 1845

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cubist Systematic Strategies's AUPH Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Aurinia Pharmaceuticals (AUPH) in Q3 2025: 50,685 shares worth $560K. The stake represents ﹤0.01% of the portfolio and ranks #2229 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in AUPH as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in AUPH in Q4 2017 and has held it in 20 quarters since. The position peaked at $3.4M in Q1 2022. 242 funds tracked by Wall St. Rank hold AUPH as of Q3 2025.

  • Cubist Systematic Strategies held 50,685 shares of Aurinia Pharmaceuticals worth $560K as of Q3 2025.
  • Aurinia Pharmaceuticals was a new Cubist Systematic Strategies position in Q3 2025.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2229 holding.
  • Cubist Systematic Strategies first reported a position in Aurinia Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • Cubist Systematic Strategies's Aurinia Pharmaceuticals position peaked at $3.4M in Q1 2022.
  • 242 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.